Ductus Arteriosus, Patent: Clinical Trials

137 trials for Ductus Arteriosus, Patent, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

69 completed, 31 unknown, 12 terminated, 8 recruiting. 35 Not applicable, 26 Phase 2, 19 Phase 3, 8 Phase 4, 4 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable35Completed 21, Terminated 4, Unknown 4, Not yet recruiting 2, Withdrawn 2, Active not recruiting 1, Recruiting 1
Phase 226Completed 10, Unknown 8, Terminated 3, Recruiting 2, Withdrawn 2, Suspended 1
Phase 319Completed 11, Terminated 3, Unknown 3, Active not recruiting 1, Suspended 1
Phase 48Completed 3, Terminated 2, Unknown 2, Withdrawn 1
Phase 14Completed 2, Terminated 1, Unknown 1
Early Phase 11Completed 1

Follow Ductus Arteriosus, Patent: new trials by email Literature Review of Ductus Arteriosus, Patent trials Research Report on Ductus Arteriosus, Patent

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Radiological Markers for PDA Management in Preterm Infants
Organ doppler, Echocardiography - Patent Ductus Arteriosus in Preterm Infants
Not applicableNot yet recruitingAssiut University882027-01-012026-09-10
HeartR™ PDA Occluder Post-Market Follow-Up Study
HeartR™ PDA Occluder - Patent Ductus Arteriosus
RecruitingLifetech Scientific (Shenzhen) Co., Ltd.1402025-04-302026-06-15
Dynamic Changes of Ductus Arteriosus in < 31 Weeks Preterm Infants: an Observational Study
observation group, control group - Preterm, Ductus Arteriosus
Active not recruitingDaping Hospital and the Research Institute of Surgery of the Third Military Medical University2002025-04-012025-04-30
PREEMIE: Study for Treatment of PDA in Premature Infants
Bloom Micro Occluder System - Patent Ductus Arteriosus (PDA)
Not applicableActive not recruitingMerit Medical Systems, Inc.552025-03-062026-10-07
Prophylactic IV Paracetamol in Extremely Premature Infants
Paracetamol (drug) - Patent Ductus Arteriosus in Preterm Infants, Patent Ductus Arteriosus After Premature Birth
Phase 2 / Phase 3CompletedAl-Quds University402025-01-012026-04-07
PDA for Kidneys Study
Near Infrared Spectroscopy - Patent Ductus Arteriosus, Congenital Heart Disease
Active not recruitingUniversity of Wisconsin, Madison272024-12-192026-09-21
Outcome of Transcatheter Closure of Patent Ductus Arteriosus in Pediatric Cardiology Unit in 3 Years Duration
transcatheter closure - Patent Ductus Arteriosus (PDA)
Not applicableNot yet recruitingAssiut University902024-10-252024-10-22
NeoDoppler: New Ultrasound Technology for Continuous Monitoring of Cerebral Circulation Pilot
NeoDoppler - CE certified - Preterm, Patent Ductus Arteriosus
RecruitingSt. Olavs Hospital1802024-10-202026-04-23
Study of Thoracic Ultrasound As a Response to the Closure of Hemodynamically Significant Patent Ductus Arteriosus in Premature Infants
Patent Ductus Arteriosus in neonates - Patency of the Ductus Arteriosus
UnknownFondazione Policlinico Universitario Agostino Gemelli IRCCS502024-09-202024-10-15
Precision Dosing of Oral Ibuprofen for PDA, A Pilot RCT
Standard Dose - Ibuprofen oral suspension, Precision Dose - Ibuprofen oral suspension - Patent Ductus Arteriosus, Preterm
Phase 2RecruitingHamilton Health Sciences Corporation262024-07-042025-08-27
The Role of Thiamine After Transcatheter Closure in Children With Left-to-Right Shunt Congenital Heart Disease
Thiamine - Congenital Heart Disease, Thiamine Deficiency
Early Phase 1CompletedUniversitas Sumatera Utara862024-05-012026-03-24
Assessment of Therapeutic Effect of Rectal Vs. Intravenous Paracetamol in The Treatment of Patent Ductus Arteriosus (PDA) in Neonates
Paracetamol - Patent Ductus Arteriosus
Phase 1 / Phase 2UnknownSoha mahmoud Hussien mahdy1002024-03-012024-02-13
Long Term Follow-up of the TREOCAPA Study (TREOCAPA-LT)
2 year follow-up of neurodevelopment using a parental questionnaire - Patency of the Ductus Arteriosus Acetaminophen Extreme Prematurity
RecruitingInstitut National de la Santé Et de la Recherche Médicale, France5002023-12-122026-04-16
Comparision Between Paracetamol and Ibuprofen in Closure of Patent Ductus Arteriosus
Paracetamol, Ibuprofen - Patent Ductus Arteriosus
Phase 2UnknownAssiut University562023-12-012023-12-01
PUFAs in Preterm Infants
Necrotizing Enterocolitis, Intraventricular Hemorrhage
UnknownThe First Hospital of Jilin University6002023-09-212023-09-21
Betamethasone and Closure of Ductus Arteriosus
DA closure in a population of premature infants - Persistent Ductus Arteriosus
UnknownHospices Civils de Lyon512023-05-012024-01-18
Percutaneous Intervention Versus Observational Trial of Arterial Ductus in Low Weight Infants
Percutaneous Patent Ductus Arteriosus Closure (PPC), Responsive Management Intervention, Echocardiogram, cardiac - Ductus Arteriosus, Patent
Not applicableRecruitingNationwide Children's Hospital2402023-02-212025-03-30
Liver Regional Oxygen Saturation in Preterm Patent Ductus Arteriosus
near-infrared spectroscopy based cerebral/somatic oximeter system (INVOS™ system manufactured by Medtronics) - Patent Ductus Arteriosus, Circulation
CompletedSeoul St. Mary's Hospital402023-01-132025-05-30
Co-administration of Acetaminophen With Ibuprofen to Improve Duct-Related Outcomes in Extremely Premature Infants
Acetaminophen Injection, Ibuprofen 20 mg/mL oral suspension or Ibuprofen lysine 10 mg/mL injection solution (Neoprofen), Sodium chloride 0.9% injection - Patent Ductus Arteriosus After Premature Birth
Phase 2RecruitingMount Sinai Hospital, Canada3102022-12-122026-09-15
Hemodynamically Important Patent Ductus Arteriosus in Newborns Under 32 Weeks
Echocardiography, Doppler ultrasonography, Near-infrared spectroscopy - Patent Ductus Arteriosus After Premature Birth
UnknownAnkara University702022-07-012023-01-17

Showing 20 of 137. Sign in to see all of them.

Narrower conditions

Premature Birth (42)  ·  Bronchopulmonary Dysplasia (10)  ·  Heart Defects, Congenital (9)  ·  Enterocolitis, Necrotizing (6)  ·  Heart Septal Defects, Atrial (6)  ·  Cardiovascular Diseases (3)  ·  Heart Septal Defects, Ventricular (3)  ·  Leukomalacia, Periventricular (3)  ·  Respiratory Distress Syndrome (3)  ·  Aortic Coarctation (2)  ·  Aortic Valve Stenosis (2)  ·  Apnea (2)  ·  Bradycardia (2)  ·  Disease (2)

Broader conditions

Cardiovascular Abnormalities (137)  ·  Congenital Abnormalities (137)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (137)  ·  Heart Diseases (135)  ·  Cardiovascular Diseases (134)  ·  Heart Defects, Congenital (128)  ·  Female Urogenital Diseases and Pregnancy Complications (43)  ·  Urogenital Diseases (43)  ·  Obstetric Labor Complications (42)  ·  Obstetric Labor, Premature (42)  ·  Pregnancy Complications (42)  ·  Respiratory Tract Diseases (18)  ·  Lung Diseases (15)  ·  Infant, Newborn, Diseases (12)  ·  Infant, Premature, Diseases (10)

Interventions

Ibuprofen (34)  ·  Acetaminophen (26)  ·  Indomethacin (13)  ·  Echocardiography (6)  ·  Sodium Chloride (5)  ·  Spectroscopy, Near-Infrared (5)  ·  Saline Solution (3)  ·  Anti-Inflammatory Agents, Non-Steroidal (2)  ·  Conservative Treatment (2)  ·  Control Groups (2)  ·  Cyclooxygenase Inhibitors (2)  ·  Infusions, Intravenous (2)  ·  Watchful Waiting (2)  ·  Angptl4 protein, mouse (1)  ·  Cardiovascular Surgical Procedures (1)

Sponsors

Shaare Zedek Medical Center (8)  ·  IRCCS Azienda Ospedaliero-Universitaria di Bologna (5)  ·  Zekai Tahir Burak Women's Health Research and Education Hospital (5)  ·  Abbott Medical Devices (4)  ·  Albany Medical College (4)  ·  Assiut University (4)  ·  University of Florida (4)  ·  Lifetech Scientific (Shenzhen) Co., Ltd. (3)  ·  Nationwide Children's Hospital (3)  ·  University of California, San Francisco (3)  ·  University of Utah (3)  ·  Ain Shams University (2)  ·  Ankara University (2)  ·  Charite University, Berlin, Germany (2)  ·  Daping Hospital and the Research Institute of Surgery of the Third Military Medical University (2)

Countries

United States (39)  ·  Italy (11)  ·  Israel (10)  ·  Turkey (Türkiye) (10)  ·  France (9)  ·  Canada (8)  ·  China (6)  ·  Germany (6)  ·  Finland (4)  ·  Sweden (4)  ·  United Kingdom (4)  ·  Indonesia (3)  ·  Ireland (3)  ·  Switzerland (3)  ·  Belgium (2)

Top investigators

Cathy Hammerman, MD (6)  ·  Barbara Schmidt, MD (2)  ·  Carl H Backes, MD (2)  ·  Christoph Czernik, MD (2)  ·  Howard Berger, MD (2)  ·  Outi Aikio, MD, PhD (2)  ·  Ronald Clyman, M.D. (2)  ·  Silvia Martini, MD (2)  ·  Aaron Pitzele, MD (1)  ·  Adelina Pellicer, PhDMD (1)  ·  Akiva Tamir, M.D (1)  ·  Alan M Fujii, MD (1)  ·  Alexander Nadas (1)  ·  Alper Aykanat (1)  ·  Alwi Mazeni, Dr (1)

Results publications

PMID 22065264, PMID 36519620, PMID 17307535, PMID 23258386, PMID 26283668, PMID 11430325, PMID 12622582, PMID 15619281, PMID 15701582, PMID 16219273, PMID 16322159, PMID 16647401, PMID 16681450, PMID 16769377, PMID 17188612, PMID 17307530, PMID 17545385, PMID 17564958, PMID 18245398, PMID 18254095, PMID 18615091, PMID 18628265, PMID 19047225, PMID 19117897, PMID 19128748, PMID 19217726, PMID 19432837, PMID 19902266, PMID 19956811, PMID 20336076, PMID 20336077, PMID 20368313, PMID 21094951, PMID 21317433, PMID 21727276, PMID 21760564, PMID 22089267, PMID 22284563, PMID 22414886, PMID 22611117, PMID 22718329, PMID 23234752, PMID 23460349, PMID 23472765, PMID 23543702, PMID 24223740, PMID 24321538, PMID 24359938, PMID 24532416, PMID 24753708

NIH funding

2019 (2), 2016 (1), M01RR000070 (1), M01RR000997 (1), R01HL039052 (1), R01HL145032 (1), U10HD021364 (1), U10HD021373 (1), U10HD021385 (1), U10HD021397 (1), U10HD027851 (1), U10HD027880 (1), U10HD027881 (1), U10HD027904 (1), U10HD034216 (1)